Lifeboost, LLC – Trademark Portfolio
Entity Type: 16
Lifeboost, LLC holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 30 (Staple Foods) — 12 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 12 trademarks are registered. Notable registered marks include EVERLO, EMBOLDEN, OPTIMIST, LIFEBOOST, and TRUSTPURE. The owner is based in Cheyenne, WY.
1623 Central Avenue, Suite 18
Cheyenne, WY 82001
Showing of trademarks Trademarks
Trademark Classifications
Lifeboost, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Frequently Asked Questions
How many trademarks does Lifeboost, LLC have?
Lifeboost, LLC has 15 U.S. trademarks filed with the USPTO. Of these, 12 registered, 2 abandoned, 1 cancelled.
What trademark classes does Lifeboost, LLC file in?
Lifeboost, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 30 (Staple Foods), Class 5 (Pharmaceuticals), Class 21 (Housewares), Class 29 (Meats & Processed Foods). Class 30 covers coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations.
What are Lifeboost, LLC's most well-known trademarks?
Lifeboost, LLC's registered trademark portfolio includes well-known marks such as EVERLO, EMBOLDEN, OPTIMIST, LIFEBOOST, and TRUSTPURE. These are among 12 currently registered trademarks in the portfolio.
What is Lifeboost, LLC's trademark registration success rate?
Lifeboost, LLC has a 80% trademark registration rate, with 12 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.